HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.
Meeting NewsVideo

VIDEO: Managing immune-related adverse events requires multidisciplinary approach

April 13, 2017
NEW YORK — Kathleen M. Madden, MSN, FNP, AOCNP, APHN, a nurse practitioner at the Laura and Isaac Perlmutter Cancer Center at the NYU Langone…
Meeting NewsVideo

VIDEO: Speaker offers updates on combinations, sequencing of immunotherapies for melanoma

April 12, 2017
NEW YORK — Michael A. Postow, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, addressed the use of immune checkpoint…
Meeting NewsVideo

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma

April 9, 2017
NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be…
Meeting NewsVideo

VIDEO: Molecular alterations may identify intermediate stages of melanoma progression

April 8, 2017
NEW YORK — Boris C. Bastian, MD, PhD, director of the Clinical Cancer Genomics Laboratory at Hellen Diller Family Comprehensive Cancer Center…
Meeting NewsVideo

VIDEO: Gene mutation analysis an ‘important piece’ of melanoma diagnosis

April 3, 2017
NEW YORK — Klaus J. Busam, MD, director of the dermatopathology service at Memorial Sloan Kettering Cancer Center, highlighted the role of…
Meeting News

10 takeaways from HemOnc Today Melanoma and Cutaneous Malignancies

March 31, 2017
The HemOnc Today Melanoma and Cutaneous Malignancies meeting offered the latest news, perspectives and interviews with leading clinicians on the…
Meeting NewsVideo

VIDEO: Immunotherapy research only at ‘tip of the iceberg’

March 31, 2017
NEW YORK — Jason J. Luke, MD, FACP, assistant professor of medicine at The University of Chicago Medicine, discussed the future of…
Meeting NewsVideo

VIDEO: Effective therapies needed for uveal melanoma

March 30, 2017
NEW YORK — Some clinical trials evaluating standard melanoma immunotherapies have been disappointing for metastatic uveal melanoma, Alexander
Meeting News

Few patients with thick melanoma may benefit from preoperative PET/CT

March 29, 2017
NEW YORK — Treatment plans for patients with thick melanoma can change based on findings from preoperative PET/CT, according to results of a…
Meeting NewsVideo

VIDEO: Intralesional therapies may improve personalized care for patients with melanoma

March 28, 2017
NEW YORK — Merrick I. Ross, MD, professor in the department of surgery at The University of Texas MD Anderson Cancer Center, discussed the…